Therefore, it is recommended that women with atypical ductalhyperplasia or lobular neoplasia undergo screening in a mannersimilar to that recommended for women with BRCA1 or BRCA2 genemutations. This evidence concerns the gene BRCA1 and lobular neoplasia.